Defeating the commercial determinants of health: what is the role of research?

Date

20 December 2024

Place

ISPUP Auditorium

On December 20th, at 2:00 pm, Christopher Millett will present a seminar entitled: “Defeating the commercial determinants of health: what is the role of research?”. It will take place at ISPUP auditorium and it has free admission.

Abstract:

Unhealthy commodity industries are a key driver of poor health and health inequalities globally. These industries have well developed strategies to counter regulatory action that may restrict their power and activities. In this seminar, Christopher will present his reflections on the important role of research in defeating the commercial determinants of health, including the nature, timing and dissemination of the research we conduct. He will present some examples of his work on tobacco control, food systems and fossil fuels.

More about Christopher Millett:

Christopher Millett is Professor of Public Health at Imperial College London. He is Visiting Professor at the National School of Public Health, NOVA University Lisbon. Christopher moved to Europe from Australia in 1994, working in several research and NHS public health roles in London before undertaking formal public health training. He completed his PhD at Imperial College in 2008 and was awarded a 5 year NIHR Research Professorship in 2014. He is a Fellow of the UK Faculty of Public Health.

Christopher is lead investigator at Imperial College for the NIHR School of Public Health Research. and Co-Principal Investigator for an NIHR Global Health Research Centre on NCDs and Environmental Change in Bangladesh, India and Indonesia. Christopher has published studies on a variety of topics, including tobacco control, active travel, nutrition, health system performance and health inequalities. His main research interest is public health policy evaluation, with a particular interest in health inequality impacts. This includes a focus on evaluating dual benefit strategies to prevent non-communicable diseases and limit environmental degradation in middle income country settings.